Literature DB >> 20486907

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

K D S Watt1, R A Pedersen, W K Kremers, J K Heimbach, M R Charlton.   

Abstract

Although mortality rates following liver transplantation (LT) are well described, there is a lack of detailed, prospective studies determining patterns of and risk factors for long-term mortality. We analyzed the multicenter, prospectively obtained The National Institute of Diabetes and Digestive and Kidney Diseases LT Database of 798 transplant recipients from 1990 to 1994 (follow-up 2003). Overall, 327 recipients died. Causes of death >1 year: 28% hepatic, 22% malignancy, 11% cardiovascular, 9% infection, 6% renal failure. Renal-related death increased dramatically over time. Risk factors for death >1 year (univariate): male gender, age/decade, pre-LT diabetes, post-LT diabetes, post-LT hypertension, post-LT renal insufficiency, retransplantation >1 year, pre-LT malignancy, alcoholic disease (ALD) and metabolic liver disease, with similar risks noted for death >5 years. Hepatitis C, retransplantation, post-LT diabetes, hypertension and renal insufficiency were significant risk factors for liver-related death. Cardiac deaths associated with age, male gender, ALD, cryptogenic disease, pre-LT hypertension and post-LT renal insufficiency. In summary, the leading causes of late deaths after transplant were graft failure, malignancy, cardiovascular disease and renal failure. Older age, diabetes and renal insufficiency identified patients at highest risk of poor survival overall. Diligent management of modifiable post-LT factors including diabetes, hypertension and renal insufficiency may impact long-term mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20486907      PMCID: PMC2891375          DOI: 10.1111/j.1600-6143.2010.03126.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.

Authors:  A Jain; J Reyes; R Kashyap; S F Dodson; A J Demetris; K Ruppert; K Abu-Elmagd; W Marsh; J Madariaga; G Mazariegos; D Geller; C A Bonham; T Gayowski; T Cacciarelli; P Fontes; T E Starzl; J J Fung
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

3.  The NIDDK liver transplantation database.

Authors:  Y L Wei; K M Detre; J E Everhart
Journal:  Liver Transpl Surg       Date:  1997-01

4.  Analysis of causes of death in liver transplant recipients who survived more than 3 years.

Authors:  J Pruthi; K A Medkiff; K T Esrason; J A Donovan; E M Yoshida; S R Erb; U P Steinbrecher; T L Fong
Journal:  Liver Transpl       Date:  2001-09       Impact factor: 5.799

5.  Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile.

Authors:  A Jain; A Marcos; J Reyes; G Mazariagos; R Kashyap; B Eghtesad; W Marsh; P Fontas; M De Vera; G Costa; K Patel; M Gadomski; T Starzl; J Fung
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

6.  Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.

Authors:  Ronald W Busuttil; Douglas G Farmer; Hasan Yersiz; Jonathan R Hiatt; Sue V McDiarmid; Leonard I Goldstein; Sammy Saab; Steven Han; Francisco Durazo; Michael Weaver; Carlos Cao; Tony Chen; Gerald S Lipshutz; Curtis Holt; Sherilyn Gordon; Jeffery Gornbein; Farin Amersi; Rafik M Ghobrial
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

7.  Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus.

Authors:  Preeti R John; Paul J Thuluvath
Journal:  Liver Transpl       Date:  2002-08       Impact factor: 5.799

8.  Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.

Authors:  Michael Charlton; Kris Ruppert; Steven H Belle; Nathan Bass; Daniel Schafer; Russell H Wiesner; Katherine Detre; Yuling Wei; James Everhart
Journal:  Liver Transpl       Date:  2004-09       Impact factor: 5.799

9.  Long-term probability of and mortality from de novo malignancy after liver transplantation.

Authors:  Kymberly D S Watt; Rachel A Pedersen; Walter K Kremers; Julie K Heimbach; William Sanchez; Gregory J Gores
Journal:  Gastroenterology       Date:  2009-09-18       Impact factor: 22.682

10.  The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation.

Authors:  Hwan Y Yoo; Paul J Thuluvath
Journal:  Transplantation       Date:  2002-10-15       Impact factor: 4.939

View more
  152 in total

Review 1.  Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management.

Authors:  Christophe Carenco; Stéphanie Faure; José Ursic-Bedoya; Astrid Herrero; Georges Philippe Pageaux
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

3.  Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.

Authors:  Abraham Shaked; Michele R DesMarais; Heather Kopetskie; Sandy Feng; Jeffrey D Punch; Josh Levitsky; Jorge Reyes; Goran B Klintmalm; Anthony J Demetris; Bryna E Burrell; Allison Priore; Nancy D Bridges; Peter H Sayre
Journal:  Am J Transplant       Date:  2018-12-31       Impact factor: 8.086

4.  The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation.

Authors:  Amr Badawy; Toshimi Kaido; Ahmed Hammad; Shintaro Yagi; Naoko Kamo; Atsushi Yoshizawa; Hideaki Okajima; Shinji Uemoto
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

5.  End Points for Clinical Trials in Primary Hyperoxaluria.

Authors:  Dawn S Milliner; Tracy L McGregor; Aliza Thompson; Bastian Dehmel; John Knight; Ralf Rosskamp; Melanie Blank; Sixun Yang; Sonia Fargue; Gill Rumsby; Jaap Groothoff; Meaghan Allain; Melissa West; Kim Hollander; W Todd Lowther; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-12       Impact factor: 8.237

Review 6.  Comparing outcomes of donation after cardiac death versus donation after brain death in liver transplant recipients with hepatitis C: a systematic review and meta-analysis.

Authors:  Malcolm Wells; Kris M Croome; Toni Janik; Roberto M Hernandez-Alejandro; Natasha M Chandok
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-28

7.  Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.

Authors:  Lisa B VanWagner; Samantha Montag; Lihui Zhao; Norrina B Allen; Donald M Lloyd-Jones; Arighno Das; Anton I Skaro; Samuel Hohmann; John J Friedewald; Josh Levitsky
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

Review 8.  [Psychiatric assessment of alcoholic patients on a waiting list for liver transplantation: which prognostic criteria are empirically proven?].

Authors:  M Soyka; F Stickel
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

Review 9.  Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis.

Authors:  Andreas Pascher; Maxim Nebrig; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2013-03-08       Impact factor: 5.594

10.  The role of liver transplantation or resection for patients with early hepatocellular carcinoma.

Authors:  Kuan-Chun Hsueh; Ting-Ying Lee; Chew-Teng Kor; Tsung-Ming Chen; Tzu-Ming Chang; Shun-Fa Yang; Chung-Bao Hsieh
Journal:  Tumour Biol       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.